Filing Details
- Accession Number:
- 0001209191-15-035581
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-22 17:45:41
- Reporting Period:
- 2015-04-20
- Filing Date:
- 2015-04-22
- Accepted Time:
- 2015-04-22 17:45:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1636578 | Monaghan Stephanie Obrien | C/O Aduro Biotech, Inc. 626 Bancroft Way, 3C Berkeley CA 94710 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-04-20 | 1,700 | $17.00 | 1,700 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-04-20 | 1,700 | $17.00 | 1,700 | No | 4 | P | Indirect | By son |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By son |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.